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Abstract
Inflammatory bowel disease (IBD) arises in genetically susceptible individuals as a result of an unidentified environmental
trigger, possibly a hitherto unknown bacterial pathogen. Twenty-six clinical isolates of Sutterella wadsworthensis were
obtained from 134 adults and 61 pediatric patients undergoing colonoscopy, of whom 69 and 29 respectively had IBD. S.
wadsworthensis was initially more frequently isolated from IBD subjects, hence this comprehensive study was undertaken to
elucidate its role in IBD. Utilizing these samples, a newly designed PCR was developed, to study the prevalence of this
bacterium in adult patients with ulcerative colitis (UC). Sutterella wadsworthensis was detected in 83.8% of adult patients with
UC as opposed to 86.1% of control subjects (p= 0.64). Selected strains from IBD cases and controls were studied to elicit
morphological, proteomic, genotypic and pathogenic differences. This study reports Scanning Electron Microscopy (SEM)
appearances and characteristic MALDI-TOF MS protein profiles of S. wadsworthensis for the very first time. SEM showed that
the bacterium is pleomorphic, existing in predominantly two morphological forms, long rods and coccobacilli. No differences
were noted in the MALDI-TOFmass spectrometry proteomic analysis. There was no distinct clustering of strains identified from
cases and controls on sequence analysis. Cytokine response after monocyte challenge with strains from patients with IBD and
controls did not yield any significant differences. Our studies indicate that S. wadsworthensis is unlikely to play a role in the
pathogenesis of IBD. Strains from cases of IBD could not be distinguished from those identified from controls.
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Introduction
Inflammatory bowel disease (IBD) is an idiopathic inflammatory
disorder that is comprised of two major phenotypes, Crohn’s
disease (CD) and ulcerative colitis (UC). The understanding of its
aetiopathogenesis has taken rapid strides in the last decade, with
current investigations focusing heavily on aberrations in host-
microbe interactions at the luminal intestinal surface. Genetic
defects in pathogen recognition and primary handling of microbes
by the innate immune system compounded with distinct changes
in the luminal microbiome or dysbiosis form the current backbone
of this pathogenic hypothesis [1,2]. Despite this, researchers in the
field have been striving to identify and delineate a solitary micro-
organism that can explain the initiation and perpetuation of this
chronic inflammatory process.
In this regard, anaerobic and microaerophilic bacteria residing
in the intestinal lumen have often been the neglected species,
primarily on account of the intrinsic difficulty in culturing and
isolating these organisms by using traditional microbiological
techniques. Molecular studies have demonstrated that a substan-
tial proportion of bacterial species (up to 30–40% of dominant
species) in patients with active IBD belong to phylogenetic groups
that are unusual when compared to healthy subjects [3,4]. With
this premise in mind, our laboratory has focused on enhanced and
improved bacteriological conditions for the optimum growth of
microaerophilic bacteria from colonic biopsy samples [5,6]. In our
pilot studies we noted the unusual preponderance of the rare
microaerophilic Gram negative bacterium Sutterella wadsworthensis
from cultures of biopsy samples from patients with IBD. This
unusual organism has been encountered before by Mangin et al.
who used 16S rRNA gene sequencing to create molecular
inventories of the dominant fecal bacteria in four CD patients
and four controls. They found that bacterial species which were
not commonly dominant in healthy individuals were over-
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represented in CD. One of these species included S. wadsworthensis,
which belonged to the dominant microbiota of one of the four CD
patients [7].
These bacteria were first reported when performing biochem-
ical characterization and susceptibility testing of Campylobacter
gracilis clinical isolates from patients with diverse infections of the
GI tract [8]. These organisms could be differentiated from C.
gracilis mainly by their bile resistance and cell wall fatty acid
patterns. 16S rRNA gene sequencing confirmed that these
unusual organisms were not related phylogenetically to any of
the Campylobacters, including C. gracilis, with the closest taxa
belonging to unrelated aerobes. This was ratified by a subsequent
report which demonstrated that the majority of S. wadsworthensis
strains were isolated from GI infections, only occasionally being
isolated from non-abdominal specimens, and were more likely to
be involved in serious infections than C. gracilis [9]. The
supposition was that S. wadsworthensis was a putative human
pathogen. Three other species, Sutterella stercoricanis, Sutterella
morbirenis and Sutterella parvirubra belonging to the same genera
have subsequently been identified from canine and human feces
[10,11].
The role of this group of bacteria has not been clearly elucidated
in the aetiopathogenesis of IBD. This study has for the first time
outlined the role of S. wadsworthensis in patients with IBD and
performed a comprehensive phenotypic, genotypic, proteomic and
pathogenetic characterization of this bacterial species, which will
serve as a useful benchmark for future studies.
Methods
Study subjects, specimen collection and processing
Adult patients were recruited from the Department of
Gastroenterology at the Aberdeen Royal Infirmary. These
subjects were recruited for a previous study looking at the role
of enterohepatic Helicobacter in UC [5]. A total of sixty-nine
patients with a diagnosis of UC made on the basis of histology of
colonoscopic biopsies were recruited and assessed. Sixty-five
healthy controls were contacted prior to their index colonoscopy
as part of the bowel cancer screening programme and recruited
for the study if they had documented absence of both
macroscopic and microscopic inflammation. Children were
recruited from the Departments of Paediatric Gastroenterology,
Hepatology and Nutrition at the Royal Aberdeen Children’s
Hospital and the Royal Hospital for Sick Children (Yorkhill),
Glasgow as part of an ongoing study to investigate the role of
microaerophilic colonic microbiota in de-novo paediatric IBD
(Bacteria in Inflammatory bowel disease in Scottish Children
Undergoing Investigation before Treatment: BISCUIT study).
Twenty-nine paediatric patients with newly-presenting, treat-
ment naı¨ve IBD and thirty-two paediatric controls undergoing
routine colonoscopy were included in this present study [12].
The extent and severity of disease was assigned using the
Montreal criteria [13]. Subjects were excluded if they received
antibiotics within three months prior to recruitment. Mucosal
colonic biopsies were obtained during the colonoscopy proce-
dures. One to two biopsies were used for culture work and the
rest were then transferred to a 280uC freezer for storage
pending DNA extraction and analysis.
Ethics
Ethical approval for the study was granted by the North of
Scotland Research Ethics Service, UK (reference numbers 04/
S0802/8 and 09/S0802/24). Written informed consent was
obtained from all adult subjects and from the parents of all
paediatric subjects in the study. Informed assent was also obtained
from older children who were deemed capable of understanding
the nature of the study.
Bacterial strains
Sutterella wadsworthensis strains. A total of twenty-seven
S. wadsworthensis strains were used in this study. The type strain,
DSM 14016 ( = ATCC 51579) was obtained from the German
Collection of Microorganisms and Cell Cultures (DSMZ). Another
twenty-six S. wadsworthensis strains obtained during the course of
this study were also examined.
Other bacterial strains. Twenty-eight other bacterial
strains were used in this study, obtained from international
culture collections as well as from clinical and environmental
sources: Campylobacter jejuni (NCTC 11351), Campylobacter upsaliensis
(NCTC 11540), Campylobacter fetus (NCTC 10842), Campylobacter lari
(NCTC 11352), Campylobacter coli (clinical isolate), Campylobacter
concisus (clinical isolate), Helicobacter pylori (ATCC 700392),
Helicobacter hepaticus (ATCC 51449), Helicobacter cholecystitis (ATCC
700242), Helicobacter canis (ATCC 51402), Helicobacter canadensis
(ATCC 700968), Escherichia coli (NCIMB 12201), Pseudomonas
fluorescences (clinical isolate), Pseudomonas aeruginosa (ATCC 27853),
Shigella sonnei (25931 clinical isolate), Proteus mirabilis (NCTC 3177),
Proteus vulgaris (NCTC 4157), Salmonella enteritidis (NCTC 12694),
Salmonella typhimurium (NCIMB 13284), Staphylococus aureus (NCIMB
12702), Bacillus cereus (ATCC 10876), Enterococcus faecalis (NCIMB
13280), Enterobacter aerogenes (NCIMB 10102), Listeria monocytogenes
(clinical isolate), Fusobacterium nucleotum (clinical isolate), Klebsiella
pneumonia (NCIMB 13281), Acinetobacter calcoaceticus (clinical isolate),
Yersinia fredericksenii (NCIMB 2124), and Aeromonas caviae (clinical
isolate).
Sutterella wadsworthensis growth conditions
S. wadsworthensis isolates were obtained by culturing 1–2 mucosal
biopsy samples on five selective plates, the details of which are
listed in Table 1. Biopsies were first ground in brucella broth
before the resultant suspension was added to the plates. 50 ml was
added to each plate with the exception of the filtered blood plate
where 200 ml was first passed through a 0.45 mm filter. Cultures
were incubated in a micro-aerophilic atmosphere, comprising of
5.9% oxygen, 7.2% carbon dioxide, 3.6% hydrogen and 83.3%
nitrogen at 37uC. This atmosphere was generated using
AnoxomatH Atmosphere Generating System, from MartH Micro-
biology b.v. (9200 JB Drachten, Netherlands). Plates were
reviewed twice weekly for up to one month. Any bacterial isolate
deemed Gram-negative and oxygen sensitive (by virtue of failed
subculture in room air) was identified by sequencing of the 16S
rRNA gene and sequence search on NCBI BLAST (http://blast.
ncbi.nlm.nih.gov/Blast.cgi).
Genotypic Characterization
DNA Extraction. Genomic DNA was extracted from the
colonic mucosal biopsies using the QIAamp DNA Mini Kit
(Qiagen, Crawley, UK) according to an established modification
of the manufacturer’s instructions, optimised in-house for colonic
biopsy tissue as described previously [5].
S. wadsworthensis specific primer design. For the design
of a new S. wadsworthensis -specific primer, 16S rRNA gene
sequences of all the S. wadsworthensis strains and other related
bacterial strains were obtained from the NCBI database (http://
www.ncbi.nlm.nih.gov) for multiple alignment. Nearly full length
16S rRNA sequences of S. wadsworthensis strains isolated from
clinical specimens in this study were also used for the alignment
analysis. Several primer sequences were initially designed by using
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the Primer 3 software [14] and then the most suitable one was
identified manually using the BioEdit software package (version
7.0.5.3) (http://www.mbio.ncsu.edu/BioEdit/bioedit.html). The
downloaded S. wadsworthensis specific sequences were aligned with
the newly designed primer sequences and the ones that matched to
the highly conserved 16S rRNA gene sequences of the target
species but were variable among the other bacterial species, were
selected. The 20 base pair S. wadsworthensis specific primer
sequences designed (SWF and SWR) are outlined in Table 2.
The primer sequences were then subjected to BLAST analysis
against all the other sequences within the BLAST database to
ensure that at least one of the primers did not share any identical
sequence with any microorganisms other than S. wadsworthensis.
Optimization of S. wadsworthensis PCR assay. The
specificity of the newly developed S. wadsworthensis primer pair
was tested against a wide panel of bacterial species as listed earlier
in the methods section. The PCR assay was tested using 40 ng of
bacterial DNA in a 50 ml reaction mixture consisting of 10 pmol of
each primer (SWF and SWR [Sigma-Aldrich, UK]), 1X PCR
buffer (Roche, UK), 250 nM of each deoxy-nucleotide-
triphosphate (Bioline, UK), 2 mM MgCl2 (Roche, UK) and 1 U
of Taq polymerase (Roche,UK). The sensitivity of the PCR assay
was determined by serially diluting a known quantity of target
DNA (50 ng/ml to 0.005 pg/ ml) to detect the minimum
concentration that would yield a visible amplicon after gel
electrophoresis.
Restriction fragment length polymorphism (RFLP) analysis was
also done using the 555 bp S. wadsworthensis-specific PCR products
using EcoR I and Hha I enymes to confirm that the PCR products
were from a single bacterial species.
Sequence Analysis. Sequencing was done on an Applied
Biosystems model 3730 automated capillary DNA sequencer using
the S. wadsworthensis - specific primers SWF and SWR or 16S rRNA
specific universal bacterial primers for the whole gene amplification
of the S. wadsworthensis strains. The sequences obtained were
compared to those of the National Center for Biotechnology
Information GenBank database using the basic local alignment
search tool (BLAST) search program. Multiple alignments and
phylogenetic analysis were performed using Bioedit (http://www.
mbio.ncsu.edu/BioEdit/bioedit.html) (version 7.0.5.3) and a
dendogram was constructed using MEGA version 4 software [15].
The evolutionary distances were calculated according to Kimura’s
two-parameter model. A phylogenetic tree was inferred using the
neighbor-joining algorithm, and the tree topology was statistically
evaluated by 1,000 bootstrap resamplings.
GenBank Sequence Submission. All 16S rRNA gene
sequences derived from the sequencing of S. wadsworthensis-
specific PCR products were submitted to GenBank with the
accession numbers from JN664092-JN664117.
Phenotypic Characterization
Basic biochemical tests including Gram staining, catalase,
urease and oxidase tests were conducted using conventional
manual methods to characterize the isolates. The strains were
further characterized using the API Campy commercial biochem-
ical kit according to the manufacturer’s instructions (BioMerieux,
La Balme Les Grottes, France). The purpose of using the API kits
in this study was not to identify or name the bacteria, but to use
the biochemical tests to further characterize the S. wadsworthensis
strains. By comparing the resultant biochemical profiles, any
potential differences between the strains might be elicited. Of all
the API kits available it was assumed that API Campy would yield
the best results, as S. wadsworthensis is phenotypically similar to
Campylobacter species.
Scanning Electron Microscopy (SEM)
S. wadsworthensis strains were harvested for SEM. Bacterial cells
were suspended in 2% Glutaraldehyde in 0.1 M sodium
Cacodylate buffer (pH 7.2) for 3 hours to be fixed. The fixed
cell suspensions were then applied to glass coverslips coated with
poly-L-lysine and allowed to adhere for five minutes. Coverslips
were then rinsed with water and post-fixed with 1% Osmium
tetroxide (OsO4) for 30 minutes. They were next rinsed with water
and dehydrated through a graded ethanol series (60%, 80%, and
90%) for 10 minutes each. The sample was then left for 30 minutes
in absolute ethanol with ethanol changes every 10 minutes. The
coverslips were kept in Hexamethyldisilazane (HMDS) SigmaH for
10 minutes, and left to dry overnight. Next day, the specimen was
coated with gold using automated sputter coater EMITECH
K550 (Emitech limited, Ashford, Kent) and samples were
transferred to view S. wadsworthensis using SEM.
Proteomic Characterization
To complement the phenotypic and genotypic methods, matrix-
associated laser desorption/ionisation - time of flight mass
Table 1. Culture media used in the study.
Media Name Base Additives
Volume of biopsy
suspension added Reference
Blood agar Blood Agar Nil 50mmol -
Blood Agar Blood Agar Nil 200mmol through 0.45mm filter -
Skirrow Blood Agar Polymyxin B, Trimethoprim, Vancomycin 50mmol [27]
CVA Blood Agar Amphotericin, Cefoperazone, Vancomycin 50mmol [28]
Helicobacter Blood Agar Amphotericin, Bacitracin, Nalidixic acid,
Polymyxin B, Vancomycin
50mmol [29]
Campylobacte Blood Agar Trimethoprim, Vancomycin 50mmol [30]
doi:10.1371/journal.pone.0027076.t001
Table 2. Sequences of PCR primers designed in this study.
Primer name Sequence Reference
SWF 59- GAC GAA AAG GGA TGC GAT AA - 39 This study
SWR 59- CTG GCA TGT CAA GGC TAG GT- 39 This study
doi:10.1371/journal.pone.0027076.t002
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spectrometry (MALDI-TOF MS) was performed to further
characterize selected S. wadsworthensis strains.
Sample preparation. A total of 11 bacterial strains were
analyzed by MALDI-TOF MS: eight S. wadsworthensis isolates (4
strains obtained from healthy controls and 4 strains from IBD
patients), the S. wadsworthensis type strain DSM 14016, C. jejuni and
C. concisus strains. Approximately 5-10 mg (half a plastic loop) of
bacterial cells were harvested from fresh blood agar plates and
proteins were extracted as described by Alispahic et al. (2010) [16].
The protein extract (supernatant) was diluted, with 30%
acetonitrile in 0.1% trifluoracetic acid (Applied Biosystems, UK)
in water. Subsequently, 1 ml of diluted supernatant was mixed
with 1 ml of matrix solution (10 mg HCCA (a-cyano-4-
hydroxycinnamic acid) matrix (Bruker Daltonics, Germany) to
1 ml of a solution comprising: 500 ml acetonitrile, 475 ml UHQ
water and 25 ml trifluoroacetic acid). 1 ml of the sample-matrix
mixture was pipetted onto a MALDI ground steel target plate
(Bruker Daltonics) and left to dry on air.
MALDI-TOF MS. Mass spectra were acquired using an
ultrafleXtremeTM series MALDI-TOF MS (Bruker Daltonics),
equipped with a 1 kHz smartbeam-IITM nitrogen laser
(l= 337 nm). Spectra were recorded using the linear positive
mode for masses in the range of 2 kDa to 20 kDa. The parameter
settings were as follows: ion source 1, 25 kV; ion source 2,
23.85 kV; lens, 6.5 kV; pulse ion extraction time, 160 ns. A low-
mass gate of 800 Da was used. Insulin, ubiquitin, cytochrome C
and myoglobin were used as external calibrants, enabling a mass
accuracy of 60.5 parts per 1000. Laser power and the number of
laser shots per sample were varied by the operator for optimal
performance.
Data analysis. Mass spectra were processed prior to visual
inspection using FlexAnalysis 3.3 software (Bruker Daltonics). This
included smoothing, baseline subtraction and intensity
normalisation. MALDI BioTyper software 2.0 (Bruker Daltonics)
was used to generate pseudo gel view representations of each
spectrum. The mass spectra and corresponding pseudo gel images
for each bacterial strain were then visually inspected and
compared.
Preparation of monocytes and S. wadsworthensis (whole
cell) stimulation studies
Whole venous blood was collected from six adult healthy
individuals who were not on any medications. The blood was
diluted 1:1 in RPMI 1640 (Sigma-Aldrich), layered onto
Histopaque-1077 (Sigma-Aldrich), and centrifuged at 8006g for
30 min. Peripheral blood mononuclear cells were removed from
the interface and monocytes were prepared as published earlier
[17]. The effect of S. wadsworthensis whole cell preparations was
assessed by stimulating the monocytes for up to 24 hours. Seven S.
wadsworthensis strains (4 strains obtained from healthy controls and
3 strains from IBD patients) were used in this study along with an
E. coli (S1041) as a positive control. Unstimulated monocytes were
used as a negative control.
Cytometric bead array
In order to assess whether the whole cell preparations induced
an inflammatory response, levels of TNF-a in culture supernatant
were measured at the different time points using a human
inflammatory cytokine cytometric bead array (CBA;BD Biosci-
ences). Samples were analyzed on a multifluorescence BD
FACSCaliburTM flow cytometer using BD CellQuestTMsoftware
and BDTM cytometric bead array software. Standard curves were
generated using FCAP Array SoftwareTM. Sample results were
then calculated by comparing sample CBA results to the respective
standard curve. All CBA work was performed in duplicate and
cytokine levels induced by stimulation were calculated by
subtracting unstimulated cytokine levels from each stimulated
value and expressing TNF-a levels as a fold-change relative to
TNF-a levels derived from E. coli stimulations.
Statistical Analysis
Statistical analysis was performed using the Pearson Chi
Squared, 2-tailed test or the Fisher’s exact test wherever
appropriate, utilizing Graph Pad software (San Diego, CA).
Results
Assessment of S. wadsworthensis prevalence in mucosal
colonic biopsies
Clinical information of the study population. The mean
age of the sixty-nine patients with UC was 45.6627.8 years and
46.4% were male as opposed to the sixty-five control patients
whose mean age was 64.265.6 years and 59.3% of these subjects
were male. There was a statistically significant difference in age
between the UC cohort and the control group (p,0.0001). At the
time of colonoscopy the adult patients were classified as extensive
(24.6%), left sided (63.8%) and proctitis (11.6%) according to the
Montreal criteria. During recruitment 10.1% of patients were in
clinical remission (S0), 23.2% had mild UC (S1), 46.4% had
moderate UC (S2) and the remaining 20.3% had severe UC (S3).
A total of 115 biopsy sites were analyzed from UC patients.
Twenty-four (34.8%) subjects had a single site analyzed and forty-
five (65.2%) had more than one biopsy site assessed. A single
biopsy site was analyzed from each control subject. The adult
patients served as clinical sources for the isolation of S.
wadsworthensis. The newly developed PCR was utilized to detect
the presence of S. wadsworthensis from mucosal biopsies from these
patients.
The paediatric IBD patients (n = 29, male 62.1%) had a median
age of 12.2 years (interquartile range, IQR, 9.8, 14.1 years) at the
time of recruitment out of which fifteen had CD, nine UC and five
IBD-unclassified. The paediatric control patients (n = 32, male
78.1%) had a mean age of 10.8 years (IQR, 8.3, 12.7 years) at the
time of index colonoscopy. The paediatric cohort was primarily
utilized as a source for isolation of S. wadsworthensis, which was then
utilized to develop and standardize the detection PCR.
A total of twenty-six S. wadsworthensis strains were isolated from
the mucosal colonic biopsy samples of the above mentioned study
populations. The majority of the clinical strains were obtained
from paediatric patients, ten from control and seven from IBD
patients. Six strains were obtained from adult IBD patients and
three from adult control patients.
Evaluation of the sensitivity and specificity of the newly
developed S. wadsworthensis -specific PCR assay. Twenty-
seven strains of S. wadsworthensis and twenty-eight other bacterial
strains representing a broad spectrum of bacterial species were
screened to test for the specificity of the newly designed species-
specific primers. The primer pair produced an intense band of
<555 bp from all the S. wadsworthensis strains (Figure 1). No
amplicon was observed from any of the other bacterial strains
tested. For detection of S. wadsworthensis DNA from mucosal biopsy
samples a nested PCR approach was taken where the first round
PCR was done using universal bacterial primers (27F and 1492R)
[18] followed by a second round of PCR using the S.
wadsworthensis–specific SWF and SWR primers. The optimal
thermal cycling conditions required to obtain specificity for the
S. wadsworthensis-specific PCR were: 94uC for 5 minutes, 30 cycles
of 94uC for 30 seconds, 58uC for 30 seconds, and 72uC for 2
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minutes, followed by 72uC for 15 minutes. The optimized PCR
was able to detect 0.5 pg/ml of S. wadsworthensis DNA (Figure 2).
The RFLP analysis of all the S. wadsworthensis–specific PCR
products also showed the expected banding pattern of 327 bp and
228 bp for EcoR 1 digestion and 420 bp and 135 bp for Hha I
digestion respectively.
Prevalence of S. wadsworthensis in adults with UC using
species-specific PCR. All the adult mucosal biopsy samples
were screened using the newly developed and optimized S.
wadsworthensis-specific PCR. S. wadsworthensis was detected in fifty-
seven of the sixty-nine subjects with ulcerative colitis and fifty-six
of the sixty-five controls. The prevalence of S. wadsworthensis in the
UC population was 83.8% which was similar to that in the
controls, 86.1% (p = 0.64). There was no statistically-significant
difference in the prevalence of S. wadsworthensis in male subjects as
opposed to female patients. Furthermore, no age related
differences could be demonstrated. Looking specifically at
patients with UC, no statistically-significant differences were
noted in the prevalence of S. wadsworthensis with respect to extent
or severity of UC according to the Montreal classification.
Phylogenetic Analysis. A phylogenetic tree was constructed
based on nearly full-length (,1400 bp) 16S rRNA gene sequences
of the S. wadsworthensis strains isolated from this study and
sequences of S. wadsworthensis strains and other Sutterella species
available in GenBank (Figure 3). All the S. wadsworthensis sequences
derived from this study clustered closely with the other S.
wadsworthensis sequences from GenBank and presented the
highest (99–100%) sequence identity to the S. wadsworthensis type
strain ATCC 51579. The S. wadsworthensis strains from different
geographical locations (strain ATCC 51579, strain WAL 7877 and
strain WAL 9054 originating from USA and the strains from this
study being from the UK) did not cluster into different lineages.
Also, S. wadsworthensis sequences analyzed from the UC and the
healthy controls did not cluster into separate groups in the
dendrogram. The GenBank derived sequences from the S.
parvirubra, S. stercoricanis and S. morbirenis strains each grouped into
different clusters in the dendrogram confirming different species.
Characterization of S. wadsworthensis isolates to detect
strain difference
As the PCR results revealed almost universal prevalence of S.
wadsworthensis in both IBD cases and controls, we hypothesised that
there may be differences between the strains isolated from the two
groups and so went on to study their phenotypic, morphological,
proteomic and pathogenic profiles.
Phenotypic Characterization. S. wadsworthensis was found to
be a Gram-negative pleomorphic rod shaped organism with
Figure 1. Amplification of S. wadsworthensis DNA from reference and clinical strains using the SW-F and SW-R primers. The assay
amplified a product of <555 bp in size. Lane 1:100 bp marker, Lane 2: negative control (no DNA), Lane 3: S. wadsworthensis DSM 14016, Lane 4 –
Lane 25: S. wadsworthensis isolate SW1, SW2, SW4, SW5, SW6, SW7, SW8, SW9, SW10, SW11, SW12, SW13, SW14, SW15, SW16, SW17, SW18, SW19,
SW20, SW21, SW22, SW23, Lane 26:100 bp marker.
doi:10.1371/journal.pone.0027076.g001
Figure 2. Limit of detection for the newly developed S.
wadsworthensis-specific nested PCR assay. The PCR assay was
able to detect 0.5 pg of S. wadsworthensis DNA. Lane 1: 100 bp marker,
Lane 2: negative control (no DNA), Lane 3: S. wadsworthensis DNA
50 ng/ml, Lane 4: S. wadsworthensis DNA 5 ng/ml, Lane 5: S.
wadsworthensis DNA 0.5 ng/ml, Lane 6: S. wadsworthensis DNA 50 pg/
ml, Lane 7:S. wadsworthensis DNA 5 pg/ml, Lane 8: S. wadsworthensis
DNA 0.5 pg/ml, Lane 9: S. wadsworthensis DNA 0.05 pg/ml, Lane 10: S.
wadsworthensis DNA 0.005 pg/ml.
doi:10.1371/journal.pone.0027076.g002
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Figure 3. Phylogenetic tree constructed using nearly full-length (,1400 bp) sequences of the 16S rRNA gene of S. wadsworthensis
strains from UC and controls alongside other Sutterella sequences available in GenBank. The evolutionary history was inferred using the
Neighbor-Joining method. The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) are
shown next to the branches. The tree is drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the
phylogenetic tree. The S. wadsworthenis isolates from IBD cases are marked in red and those from controls are marked in blue.
doi:10.1371/journal.pone.0027076.g003
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different morphological structures seen on Gram stain, even
though the S. wadsworthensis cultures were pure. All S. wadsworthensis
strains tested negative for catalase, urease and oxidase tests. The
API Campy kit results showed that all the S. wadsworthensis strains
tested (9 clinical isolates and the type strain) were positive for the
EST, ArgA and AspA tests, indicating they possess the enzymes
esterase, L-arginine arylamidase and L-aspartate arylamidase
respectively. The only discrepant result between the S.
wadsworthensis strains was for the HIP test; four strains, including
the type strain, tested positive and six strains were found to be
negative. This tested the ability of the bacteria to hydrolyse sodium
hippurate. A positive result indicated the presence of the enzyme
hippurate hydrolase. All the assimilation tests on the second half of
the strips were negative for all S. wadsworthensis strains.
SEM. Under conventional light microscopy, there were
clearly two different morphologies for S. wadsworthensis. For this
reason, an intensive literature search for S. wadsworthensis electron
micrographs was done. However, there were no published electron
micrograph images available to answer the morphology question.
Due to this, two S. wadsworthensis strains (SW9 from control and
SW13 from IBD) were selected for SEM. The SEM images clearly
indicated lattice formation (Figure 4A) and two distinct
morphologies of this bacterium: a long rod (nearly 4mm) and a
short cocco-bacillus (nearly 1mm) (Figure 4B). Interestingly, there
were also cells with filamentous shape (Figure 4C) and a helical
form was also observed (Figure 4D).
MALDI-TOF MS. Matrix-associated laser desorption/
ionization – time of flight mass spectrometry (MALDI-TOF MS)
is a well-established technique in proteomics for the analysis of
proteins and peptides. Profiling of proteins by MALDI-TOF MS
has been developed as a rapid and sensitive technique for
microorganism identification [16]. In the MALDI Biotyper
system developed by Bruker Daltonics, MALDI-TOF mass
spectra of small proteins (range 2–20 kDa) acquired directly
from smears of cells or their extracts are compared with reference
spectra in the MALDI Biotyper database. The most recent
MALDI Biotyper 2.0 database available (version 3.1.2, dated 28
January 2011, containing reference spectra for 3740
microorganisms) did not contain any information on S.
wadsworthensis. The purpose of MALDI-TOF MS in this study,
as with the API testing kit, was not to identify the bacterial strains
but to further characterize them and elicit any differences between
them.
Out of the eleven strains tested, triplicate samples of the first six
bacterial strains analyzed by MALDI-TOF MS were analyzed to
assess how reproducible the method was. All three replicates for
these six strains produced almost identical results, so it was decided
that obtaining a single mass spectrum for each of the remaining
five strains would be sufficient. The remaining five strains were
analyzed and the mass spectra for all 11 strains were obtained. It
was immediately apparent that there was a characteristic S.
wadsworthensis pattern that all of the strains conformed to
(Figure 5A). Notably there was a dominant peak at approximately
9400Da which was common to all S. wadsworthensis strains
(Figure 5B). The Campylobacter strains on the other hand, produced
different patterns of peaks, with C. jejuni producing a dominant
double peak at approximately 9500Da and 10300Da (data not
shown).
Monocyte challenge. A human monocyte challenge system
was used to assess the immunogenicity of different S. wadsworthensis
strains. A survival test was performed to examine the ability of S.
wadsworthensis strains to survive when exposed to the oxygen
present in the monocyte stimulation experimental setup. This
showed that .50% of S. wadsworthensis cells survived for four
hours. Seven S. wadsworthensis strains and an E. coli strain were
inoculated onto monocytes that were obtained from six healthy
Figure 4. Scanning electron microscopy (SEM) images of S. wadsworthensis showing different morphologies for this organism. Small
and large, filamentous and helical bacteria forms were observed. A) S. wadsworthensis cells formed as a lattice B) Different Sutterella cell morphologies
C) Filamentous bacterial form D) Helical bacterial form.
doi:10.1371/journal.pone.0027076.g004
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volunteers. Levels of TNF-a were measured at 4 hours of
stimulation. All S. wadsworthensis strains induced TNF-a cytokine
production from the human monocytes. Compared to the E. coli
strain used S. wadsworthensis strains induced higher levels of TNF-a
production over the first 4 hours although subsequent
measurements at 24 hours indicated that TNF-a levels remained
detectable in E. coli stimulated monocytes but that TNF-a was not
detectable in S. wadsworthensis stimulated wells, most likely because
of the death of S. wadsworthensis organisms (Table 3).
Discussion
The role of S. wadsworthensis in human gastrointestinal diseases
has been documented in the past but its specific involvement in
inflammatory bowel disease has never been firmly established
[8,9]. The fortuitous isolation of this unusual bacterial strain from
mucosal biopsies of patients with IBD prompted a series of
experiments that have been outlined in this paper and has
culminated in detailed characterization of this putative pathogen.
Despite this detailed microbial analysis no specific differences have
been identified between cases and controls. However, this negative
result does not preclude the importance of successful isolation of
this fastidious organism from colonic biopsy samples by adhering
to a strict microaerophilic culture environment and stringent
growth conditions. Our study provides an important proof of
concept that will enable future studies to satisfy Koch’s postulates
to tie in other luminal microaerophilic bacteria as causative factors
in IBD.
This is the first report of the appearances of this bacterial species
under scanning electron microscopy (SEM). As opposed to
previous descriptions, the bacteria are pleomorphic, with strains
existing in predominantly two morphological forms, long rods and
coccobacilli. Filamentous and helical forms were also documented.
The bacteria appeared in clusters on Gram stain and this was
further corroborated with the appearance of a lattice type network
on SEM. The functional role of this lattice formation is unclear,
but given the high prevalence of this organism that we have
demonstrated in the human colonic mucosa, further investigation
of the interaction of S. wadsworthensis in the complex luminal
microbiota may be of interest. This lattice structural network may
paradoxically harbour either commensal bacteria or pathogenic
bacterial strains in close juxtaposition to the epithelial surface with
diametrically opposite consequences.
All S. wadsworthensis strains were negative for urease, catalase
and oxidase, consistent with the initial description by Wexler et al
[8]. The authors had described S. wadsworthensis as asaccharolytic,
and certainly none of the sugar assimilation tests from the API kit
were found to be positive [8]. As S. wadsworthensis is phenotypically
closely related to the Campylobacter genus, the API Campy kit,
specifically for the identification of Campylobacter species was
trialed. This yielded more promising results. All of the S.
wadsworthensis strains tested were positive for the EST, ArgA and
AspA tests, meaning they possessed the enzymes esterase, L-
arginine arylamidase and L-aspartate arylamidase respectively.
Esterases are often required to breakdown dietary residue and are
mostly derived from the intestinal microbiota, with E. coli,
Bifidobacterium and Lactobacillus species all known to be sources
[19]. Colonic esterases have been shown to release powerful
antioxidants, present in cereal bran, from complex ester-linked
structures which could otherwise not be absorbed [20]. It is
possible that the esterases produced by S. wadsworthensis have a
similar role.
This study utilized a newly developed PCR to detect the
presence of S. wadsworthensis in a subset of adult patients with UC
and adult control patients. The rates of detection was similar in
both these groups (83.8% vs. 86.1%, p = 0.64), suggesting that this
bacterial strain is probably a commensal. The only other study
that has looked at the prevalence of this pathogen in patients with
gastrointestinal disease was by Engberg et al. who used PCR and
DNA sequencing of the 16S rRNA gene to characterize bacterial
populations in fecal samples [21]. They detected S. wadsworthensis
in only 7 out of 1483 (0.47%) patients with GI disorders, and only
1 out of 107 (0.93%) healthy individuals. This wide disparity in
prevalence between this study and our cohort of patients and
controls suggests that S. wadsworthensis is closely adherent to the
mucosal lining and is more likely to be identified from biopsy
samples as opposed to feces. Additionally, this newly designed
PCR for this bacterial strain was validated using the type strain of
S. wadsworthensis as well as several related bacterial strains and will
form a useful tool in future studies.
Despite similar rates of detection of S. wadsworthensis from
patients with IBD and controls, our clinical isolates gave us an
excellent opportunity to further characterize this organism.
Several bacterial species have been noted to have distinctly
different phenotypic and genotypic profiles when isolated from
patients with clinical disease as opposed to controls. This has been
recently documented in Campylobacter concisus and mucosa associ-
ated E. coli wherein distinct genomospecies have been documented
with varying pathogenic potential [22,23]. Sequence analysis of
strains identified during the study from cases and controls did not
cluster in distinct groups confirming that this phenomenon does
not extend to S. wadsworthensis.
Proteomic analysis of S. wadsworthensis strains utilizing MALDI-
TOF MS is being reported for the first time in this paper. MALDI-
TOF MS has recently emerged as an alternative to phenotypic
and genotypic methods for the fast and reliable identification of
Figure 5. Mass spectra obtained for S. wadsworthensis strains. (A) Spectra obtained for 6 S. wadsworthensis strains: S. wadsworthensis type
strain, SW1, SW4, SW5, SW6 and SW7. All of the S. wadsworthensis strains conform to a common pattern. a.u. arbitary unit; m/z, mass-to-charge ratio;
Da, Daltons; (B) Overlaid spectra of five S. wadsworthensis strains overlaid. This is a close-up of the mass spectra from 8,700 Da to 10,500 Da. It shows
how closely each S. wadsworthensis mass spectrum, aside from intensity, matches the others. a.u., arbitary unit; m/z, mass-to-charge ratio; Da, daltons.
doi:10.1371/journal.pone.0027076.g005
Table 3. TNF-a levels (depicted as percentage) derived from
human monocytes (N= 6) exposed to whole cell preparations
of various S. wadsworthensis strains.
SW1 SW2 SW3 SW7 SW8 SW9 SW13
Volunteer A 3 407 62 43 64 92 128
Volunteer B 0 651 184 108 200 178 NT
Volunteer C 17 120 908 125 120 120 NT
Volunteer D 747 924 197 360 350 541 NT
Volunteer E 163 625 117 237 237 429 NT
Volunteer F NT NT NT NT NT NT 139
TNF-a production in the supernatant was determined after 4 hours of
stimulation. The cytokine amounts shown are expressed as a percentage of the
cytokine induction by whole cell E. coli preparations. NT =not tested.
doi:10.1371/journal.pone.0027076.t003
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microorganisms down to the species level [16,24,25,26]. It can be
used to classify closely related bacteria, which may be indistin-
guishable by conventional methods [24]. It was therefore
employed to investigate the diversity of the S. wadsworthensis
protein profiles. A characteristic pattern was clearly demonstrated
on the analysis of S. wadsworthensis strains, with a dominant peak at
approximately 9400Da. Although no major differences were
detected between the strains, MALDI-TOF MS proved to be a
highly sensitive and reproducible method for the characterization
of the bacterial mass spectra. Very small mass of sample were
required, which was ideal for analyzing the slow and modest
growing S. wadsworthensis. This finding will provide a useful
reference for future studies and an alternative to genotypic
methods like 16S rRNA gene sequencing.
The in-vitro cytokine analysis after monocyte challenge failed to
show any distinct differences between strains isolated from patients
with IBD and controls. This last finding essentially closes the loop
in the series of studies looking at the possible role of S.
wadsworthensis in IBD. Our experiments have conclusively shown
that the prevalence of this bacterium is similar in IBD patients and
controls and that there is no phenotypic, genotypic, proteomic or
pathogenic characteristic to distinguish bacteria isolated from
these two groups of patients. It is quite likely that S. wadsworthensis is
a commensal and a harmless bystander amidst the inflammatory
cascade that is typical of inflammatory bowel disease.
Acknowledgments
We would like to thank all adult gastroenterologists (Aberdeen Royal
Infirmary) and paediatric gastroenterologists (Royal Aberdeen Children’s
Hospital and Royal Hospital for Sick Children, Glasgow) for their
assistance in recruiting patients to this study. We would also like to thank
the patients, children and families who gave their time and consent to
participate in this research.
We gratefully acknowledge the technical assistance of Mr Ian Davidson
for help with MALDI-TOF MS and Mr Kevin MacKenzie for expertise in
SEM. We also thank Bruker Daltonics for providing the MALDI BioTyper
software.
Author Contributions
Conceived and designed the experiments: IM RH EME-O GLH.
Performed the experiments: IM RH CEN YAA SHB CP DAS. Analyzed
the data: IM RH JMT RKR GLH. Contributed reagents/materials/
analysis tools: JMT RKR EME-O. Wrote the paper: IM RH GLH.
References
1. Hansen R, Thomson JM, El-Omar EM, Hold GL (2010) The role of infection in
the aetiology of inflammatory bowel disease. J Gastroenterol 45: 266–276.
2. Khor B, Gardet A, Xavier RJ (2011) Genetics and pathogenesis of inflammatory
bowel disease. Nature 474: 307–317.
3. Marteau P (2009) Bacterial flora in inflammatory bowel disease. Dig Dis
27(Suppl 1): 99–103.
4. Sokol H, Seksik P, Rigottier-Gois L, Lay C, Lepage P, et al. (2006) Specificities
of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis 12:
106–111.
5. Thomson JM, Hansen R, Berry SH, Hope ME, Murray GI, et al. (2011)
Enterohepatic helicobacter in ulcerative colitis: potential pathogenic entities?
PLoS One 6: e17184.
6. Mukhopadhya I, Thomson JM, Hansen R, Berry SH, El-Omar EM, et al. (2011)
Detection of Campylobacter concisus and Other Campylobacter Species in
Colonic Biopsies from Adults with Ulcerative Colitis. PLoS One 6: e21490.
7. Mangin I, Bonnet R, Seksik P, Rigottier-Gois L, Sutren M, et al. (2004)
Molecular inventory of faecal microflora in patients with Crohn’s disease. FEMS
Microbiol Ecol 50: 25–36.
8. Wexler HM, Reeves D, Summanen PH, Molitoris E, McTeague M, et al. (1996)
Sutterella wadsworthensis gen. nov., sp. nov., bile-resistant microaerophilic
Campylobacter gracilis-like clinical isolates. Int J Syst Bacteriol 46: 252–258.
9. Molitoris E, Wexler HM, Finegold SM (1997) Sources and antimicrobial
susceptibilities of Campylobacter gracilis and Sutterella wadsworthensis. Clin
Infect Dis 25(Suppl 2): S264–265.
10. Sakon H, Nagai F, Morotomi M, Tanaka R (2008) Sutterella parvirubra sp. nov.
and Megamonas funiformis sp. nov., isolated from human faeces. Int J Syst Evol
Microbiol 58: 970–975.
11. Greetham HL, Collins MD, Gibson GR, Giffard C, Falsen E, et al. (2004)
Sutterella stercoricanis sp. nov., isolated from canine faeces. Int J Syst Evol
Microbiol 54: 1581–1584.
12. Hansen R, Mukhopadhya I, Russell RK, Bisset WM, Berry SH, Thomson JM,
El-Omar EM, Hold LG (2011) The role of microaerophilic colonic mucosal
bacteria in de novo paediatric inflammatory bowel disease. Gut 60(Suppl 1):
A147.
13. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, et al. (2005)
Toward an integrated clinical, molecular and serological classification of
inflammatory bowel disease: Report of a Working Party of the 2005 Montreal
World Congress of Gastroenterology. Can J Gastroenterol 19(Suppl A): 5–36.
14. Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for
biologist programmers. Methods Mol Biol 132: 365–386.
15. Kumar S, Tamura K, Nei M (2004) MEGA3: Integrated software for Molecular
Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform 5:
150–163.
16. Alispahic M, Hummel K, Jandreski-Cvetkovic D, Nobauer K, Razzazi-Fazeli E,
et al. (2010) Species-specific identification and differentiation of Arcobacter,
Helicobacter and Campylobacter by full-spectral matrix-associated laser
desorption/ionization time of flight mass spectrometry analysis. J Med Microbiol
59: 295–301.
17. Haag AF, Wehmeier S, Muszynski A, Kerscher B, Fletcher V, et al. (2011)
Biochemical characterization of Sinorhizobium meliloti mutants reveals gene
products involved in the biosynthesis of the unusual lipid A very long-chain fatty
acid. J Biol Chem 286: 17455–17466.
18. Hold GL, Pryde SE, Russell VJ, Furrie E, Flint HJ (2002) Assessment of
microbial diversity in human colonic samples by 16S rDNA sequence analysis.
FEMS Microbiol Ecol 39: 33–39.
19. Selma MV, Espin JC, Tomas-Barberan FA (2009) Interaction between phenolics
and gut microbiota: role in human health. J Agric Food Chem 57: 6485–6501.
20. Andreasen MF, Kroon PA, Williamson G, Garcia-Conesa MT (2001) Esterase
activity able to hydrolyze dietary antioxidant hydroxycinnamates is distributed
along the intestine of mammals. J Agric Food Chem 49: 5679–5684.
21. Engberg J, On SL, Harrington CS, Gerner-Smidt P (2000) Prevalence of
Campylobacter, Arcobacter, Helicobacter, and Sutterella spp. in human fecal
samples as estimated by a reevaluation of isolation methods for Campylobacters.
J Clin Microbiol 38: 286–291.
22. Kalischuk LD, Inglis GD (2011) Comparative genotypic and pathogenic
examination of Campylobacter concisus isolates from diarrheic and non-
diarrheic humans. BMC Microbiol 11: 53.
23. Schippa S, Conte MP, Borrelli O, Iebba V, Aleandri M, et al. (2009) Dominant
genotypes in mucosa-associated Escherichia coli strains from pediatric patients
with inflammatory bowel disease. Inflamm Bowel Dis 15: 661–672.
24. Ilina EN, Borovskaya AD, Malakhova MM, Vereshchagin VA, Kubanova AA,
et al. (2009) Direct bacterial profiling by matrix-assisted laser desorption-
ionization time-of-flight mass spectrometry for identification of pathogenic
Neisseria. J Mol Diagn 11: 75–86.
25. Lasch P, Beyer W, Nattermann H, Stammler M, Siegbrecht E, et al. (2009)
Identification of Bacillus anthracis by using matrix-assisted laser desorption
ionization-time of flight mass spectrometry and artificial neural networks. Appl
Environ Microbiol 75: 7229–7242.
26. Kolinska R, Drevinek M, Jakubu V, Zemlickova H (2008) Species identification
of Campylobacter jejuni ssp. jejuni and C. coli by matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry and PCR. Folia Micro-
biol (Praha) 53: 403–409.
27. Skirrow MB (1977) Campylobacter enteritis: a ‘‘new’’ disease. Br Med J 2: 9–11.
28. Reller LB, Merritt S, Reimer LG (1983) Controlled evaluation of an improved
selective medium for isolation of Campylobacter jejuni from human feces
[abstract] 83rd Annu Meet Am Soc Microbiol: C274: 357.
29. Fox JG, Dewhirst FE, Shen Z, Feng Y, Taylor NS, et al. (1998) Hepatic
Helicobacter species identified in bile and gallbladder tissue from Chileans with
chronic cholecystitis. Gastroenterology 114: 755–763.
30. Zhang L, Man SM, Day AS, Leach ST, Lemberg DA, et al. (2009) Detection
and isolation of Campylobacter species other than C. jejuni from children with
Crohn’s disease. J Clin Microbiol 47: 453–455.
Role of Sutterella wadsworthensis in IBD
PLoS ONE | www.plosone.org 10 October 2011 | Volume 6 | Issue 10 | e27076
